| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enhancer Elements, Genetic | 16 | 2018 | 266 | 5.390 |
Why?
|
| Gene Expression Regulation, Developmental | 22 | 2018 | 623 | 5.050 |
Why?
|
| Multigene Family | 10 | 2018 | 202 | 2.600 |
Why?
|
| Genes, Homeobox | 8 | 2013 | 81 | 2.270 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 9 | 2015 | 148 | 1.780 |
Why?
|
| Embryonic Development | 4 | 2020 | 74 | 1.490 |
Why?
|
| Mice | 37 | 2020 | 11352 | 1.470 |
Why?
|
| Homeodomain Proteins | 11 | 2015 | 536 | 1.430 |
Why?
|
| Gene Expression Regulation | 7 | 2018 | 1920 | 1.390 |
Why?
|
| Mice, Transgenic | 15 | 2016 | 1540 | 1.290 |
Why?
|
| Promoter Regions, Genetic | 15 | 2016 | 937 | 1.230 |
Why?
|
| Transcription, Genetic | 5 | 2017 | 1135 | 1.130 |
Why?
|
| Genome | 6 | 2018 | 372 | 1.120 |
Why?
|
| Animals | 47 | 2020 | 26581 | 1.110 |
Why?
|
| Embryo, Mammalian | 6 | 2015 | 207 | 0.930 |
Why?
|
| Chromatin | 5 | 2018 | 380 | 0.930 |
Why?
|
| Evolution, Molecular | 8 | 2016 | 813 | 0.900 |
Why?
|
| F-Box Proteins | 2 | 2013 | 8 | 0.780 |
Why?
|
| Hedgehog Proteins | 3 | 2016 | 93 | 0.760 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2017 | 58 | 0.720 |
Why?
|
| Lentivirus | 2 | 2010 | 36 | 0.710 |
Why?
|
| Gene Regulatory Networks | 5 | 2016 | 296 | 0.710 |
Why?
|
| Transcription Factors | 8 | 2019 | 1565 | 0.690 |
Why?
|
| Receptors, Odorant | 1 | 2019 | 37 | 0.650 |
Why?
|
| Odorants | 1 | 2019 | 70 | 0.650 |
Why?
|
| Sea Anemones | 1 | 2018 | 15 | 0.650 |
Why?
|
| Extremities | 2 | 2011 | 165 | 0.650 |
Why?
|
| Genes, myc | 1 | 2018 | 39 | 0.630 |
Why?
|
| Chromosome Positioning | 1 | 2017 | 3 | 0.630 |
Why?
|
| DNA-Binding Proteins | 4 | 2019 | 1208 | 0.630 |
Why?
|
| Cell Cycle Proteins | 2 | 2017 | 388 | 0.610 |
Why?
|
| DNA Transposable Elements | 3 | 2015 | 169 | 0.600 |
Why?
|
| Limb Deformities, Congenital | 2 | 2008 | 21 | 0.570 |
Why?
|
| Chordata | 1 | 2016 | 9 | 0.560 |
Why?
|
| Disease | 2 | 2016 | 90 | 0.560 |
Why?
|
| Gene Order | 2 | 2013 | 22 | 0.550 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 292 | 0.540 |
Why?
|
| Prosencephalon | 1 | 2016 | 62 | 0.540 |
Why?
|
| Leukemia | 1 | 2018 | 320 | 0.540 |
Why?
|
| Chromosome Duplication | 1 | 2015 | 8 | 0.540 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2015 | 63 | 0.520 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2015 | 11 | 0.520 |
Why?
|
| Transcription Factor AP-2 | 1 | 2015 | 14 | 0.520 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 280 | 0.500 |
Why?
|
| Cleft Lip | 1 | 2014 | 15 | 0.500 |
Why?
|
| Cleft Palate | 1 | 2014 | 25 | 0.490 |
Why?
|
| RNA | 1 | 2018 | 560 | 0.480 |
Why?
|
| Morphogenesis | 2 | 2020 | 192 | 0.480 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 196 | 0.480 |
Why?
|
| Genetic Loci | 1 | 2015 | 250 | 0.470 |
Why?
|
| Genes, Switch | 1 | 2013 | 8 | 0.470 |
Why?
|
| Genetic Vectors | 2 | 2008 | 439 | 0.470 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 120 | 0.470 |
Why?
|
| Face | 1 | 2014 | 114 | 0.460 |
Why?
|
| Forelimb | 1 | 2013 | 17 | 0.460 |
Why?
|
| Binding Sites | 3 | 2014 | 1098 | 0.460 |
Why?
|
| Genomic Structural Variation | 1 | 2013 | 3 | 0.460 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2013 | 28 | 0.450 |
Why?
|
| Mice, Inbred C57BL | 7 | 2020 | 3092 | 0.440 |
Why?
|
| Trans-Activators | 4 | 2004 | 429 | 0.430 |
Why?
|
| Muscle Proteins | 1 | 2013 | 132 | 0.430 |
Why?
|
| Heart | 1 | 2015 | 539 | 0.410 |
Why?
|
| Databases, Genetic | 1 | 2013 | 260 | 0.410 |
Why?
|
| Chromosomes, Mammalian | 3 | 2013 | 36 | 0.410 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2010 | 165 | 0.400 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 294 | 0.390 |
Why?
|
| Repressor Proteins | 2 | 2014 | 403 | 0.380 |
Why?
|
| Genetic Techniques | 1 | 2011 | 72 | 0.380 |
Why?
|
| Genes, Intracisternal A-Particle | 1 | 2010 | 3 | 0.370 |
Why?
|
| Chromosomes | 3 | 2019 | 96 | 0.370 |
Why?
|
| Endogenous Retroviruses | 1 | 2010 | 10 | 0.370 |
Why?
|
| In Situ Hybridization | 4 | 2014 | 307 | 0.370 |
Why?
|
| Muscle, Skeletal | 3 | 2013 | 449 | 0.360 |
Why?
|
| Nuclear Proteins | 4 | 2010 | 696 | 0.360 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 78 | 0.350 |
Why?
|
| Nerve Tissue Proteins | 3 | 2010 | 503 | 0.350 |
Why?
|
| Genes, Reporter | 6 | 2011 | 268 | 0.350 |
Why?
|
| Neurons | 1 | 2018 | 1546 | 0.350 |
Why?
|
| Developmental Biology | 2 | 2006 | 27 | 0.350 |
Why?
|
| Gene Silencing | 1 | 2010 | 172 | 0.350 |
Why?
|
| Genomics | 3 | 2018 | 720 | 0.330 |
Why?
|
| Virus Integration | 1 | 2008 | 16 | 0.330 |
Why?
|
| Obesity | 1 | 2015 | 963 | 0.330 |
Why?
|
| Retroelements | 1 | 2008 | 44 | 0.320 |
Why?
|
| Tretinoin | 3 | 2020 | 126 | 0.310 |
Why?
|
| Mutagenesis, Insertional | 1 | 2008 | 111 | 0.310 |
Why?
|
| Transgenes | 5 | 2013 | 180 | 0.310 |
Why?
|
| Vertebrates | 1 | 2008 | 90 | 0.300 |
Why?
|
| Fructose-Bisphosphate Aldolase | 3 | 2004 | 11 | 0.300 |
Why?
|
| Humans | 27 | 2018 | 86601 | 0.280 |
Why?
|
| Chromosome Mapping | 4 | 2013 | 1074 | 0.270 |
Why?
|
| Gene Duplication | 3 | 2016 | 125 | 0.270 |
Why?
|
| Chromosome Inversion | 1 | 2005 | 47 | 0.270 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2004 | 4 | 0.250 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2004 | 4 | 0.250 |
Why?
|
| Germ Cells | 1 | 2005 | 126 | 0.250 |
Why?
|
| Chickens | 3 | 2013 | 212 | 0.250 |
Why?
|
| Gene Transfer Techniques | 2 | 2013 | 152 | 0.240 |
Why?
|
| Sequence Analysis, DNA | 4 | 2010 | 853 | 0.240 |
Why?
|
| 5' Flanking Region | 1 | 2003 | 16 | 0.230 |
Why?
|
| Sequence Deletion | 2 | 2018 | 205 | 0.230 |
Why?
|
| Chromosomes, Artificial, Bacterial | 3 | 2010 | 30 | 0.230 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 179 | 0.230 |
Why?
|
| RNA, Messenger | 3 | 2014 | 1981 | 0.230 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 273 | 0.220 |
Why?
|
| Bone Diseases, Developmental | 1 | 2002 | 11 | 0.220 |
Why?
|
| Amino Acid Motifs | 2 | 2018 | 116 | 0.220 |
Why?
|
| Hindlimb | 1 | 2002 | 89 | 0.210 |
Why?
|
| Colorectal Neoplasms | 2 | 2001 | 938 | 0.210 |
Why?
|
| Muscles | 1 | 2002 | 194 | 0.210 |
Why?
|
| Models, Genetic | 3 | 2016 | 926 | 0.210 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 879 | 0.200 |
Why?
|
| Spine | 1 | 2002 | 102 | 0.200 |
Why?
|
| Disease Models, Animal | 3 | 2015 | 2232 | 0.200 |
Why?
|
| Lac Operon | 2 | 2011 | 46 | 0.200 |
Why?
|
| Translocation, Genetic | 1 | 2002 | 265 | 0.200 |
Why?
|
| Oculomotor Muscles | 1 | 2020 | 28 | 0.190 |
Why?
|
| DNA, Complementary | 1 | 2001 | 393 | 0.190 |
Why?
|
| Interferon-beta | 1 | 2001 | 125 | 0.190 |
Why?
|
| Gene Deletion | 2 | 2018 | 329 | 0.190 |
Why?
|
| Biological Evolution | 1 | 2008 | 918 | 0.180 |
Why?
|
| Neoplasm Proteins | 2 | 2015 | 532 | 0.180 |
Why?
|
| Adenoviridae | 1 | 2001 | 345 | 0.180 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2013 | 101 | 0.180 |
Why?
|
| Base Sequence | 4 | 2008 | 2330 | 0.180 |
Why?
|
| Female | 15 | 2018 | 44507 | 0.180 |
Why?
|
| Genetic Therapy | 1 | 2001 | 342 | 0.170 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2019 | 21 | 0.170 |
Why?
|
| Myogenin | 1 | 1998 | 5 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 736 | 0.170 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2019 | 16 | 0.170 |
Why?
|
| LIM Domain Proteins | 1 | 2019 | 25 | 0.170 |
Why?
|
| Embryonic and Fetal Development | 1 | 1998 | 72 | 0.170 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1999 | 122 | 0.170 |
Why?
|
| Phenotype | 4 | 2016 | 2377 | 0.170 |
Why?
|
| Phylogeny | 2 | 2018 | 1137 | 0.170 |
Why?
|
| Tubulin | 1 | 2018 | 58 | 0.160 |
Why?
|
| Central Nervous System | 2 | 2010 | 151 | 0.160 |
Why?
|
| Multipotent Stem Cells | 1 | 2018 | 19 | 0.160 |
Why?
|
| Smell | 1 | 2019 | 109 | 0.160 |
Why?
|
| Male | 12 | 2018 | 40956 | 0.160 |
Why?
|
| Myeloid Cells | 1 | 2018 | 98 | 0.150 |
Why?
|
| Cluster Analysis | 1 | 2018 | 369 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 217 | 0.140 |
Why?
|
| Cell Lineage | 1 | 2018 | 273 | 0.140 |
Why?
|
| Congenital Abnormalities | 1 | 2016 | 63 | 0.140 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 69 | 0.140 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 143 | 0.140 |
Why?
|
| Molecular Sequence Data | 3 | 2008 | 3030 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2018 | 504 | 0.140 |
Why?
|
| Liver | 2 | 2017 | 1229 | 0.140 |
Why?
|
| Mutation | 2 | 2004 | 3967 | 0.130 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 171 | 0.130 |
Why?
|
| Branchial Region | 1 | 2015 | 10 | 0.130 |
Why?
|
| Blastocyst | 1 | 2015 | 34 | 0.130 |
Why?
|
| Actins | 1 | 2018 | 451 | 0.130 |
Why?
|
| Liver Neoplasms | 1 | 2001 | 735 | 0.130 |
Why?
|
| Syndrome | 1 | 2015 | 446 | 0.120 |
Why?
|
| CCCTC-Binding Factor | 1 | 2014 | 18 | 0.120 |
Why?
|
| Amino Acid Sequence | 3 | 2004 | 2062 | 0.120 |
Why?
|
| Limb Buds | 2 | 2004 | 6 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2018 | 1538 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 133 | 0.120 |
Why?
|
| Oryzias | 1 | 2013 | 5 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 1169 | 0.120 |
Why?
|
| Transcriptome | 1 | 2018 | 580 | 0.120 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2014 | 135 | 0.120 |
Why?
|
| Integrases | 1 | 2013 | 59 | 0.120 |
Why?
|
| Lymphatic Metastasis | 3 | 2000 | 481 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 479 | 0.120 |
Why?
|
| Green Fluorescent Proteins | 2 | 2013 | 305 | 0.110 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 724 | 0.110 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2005 | 348 | 0.110 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 113 | 0.110 |
Why?
|
| Epistasis, Genetic | 1 | 2013 | 86 | 0.110 |
Why?
|
| Telomere | 1 | 2013 | 108 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1384 | 0.110 |
Why?
|
| Organ Specificity | 1 | 2013 | 258 | 0.110 |
Why?
|
| Alleles | 2 | 2008 | 1127 | 0.110 |
Why?
|
| Gene Dosage | 1 | 2013 | 207 | 0.110 |
Why?
|
| User-Computer Interface | 1 | 2013 | 185 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2016 | 729 | 0.100 |
Why?
|
| Xenopus | 1 | 2011 | 125 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 763 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2018 | 1458 | 0.100 |
Why?
|
| Transposases | 1 | 2011 | 21 | 0.100 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2010 | 5 | 0.100 |
Why?
|
| Mice, Inbred DBA | 2 | 2020 | 148 | 0.100 |
Why?
|
| Cell Nucleus | 3 | 2004 | 579 | 0.100 |
Why?
|
| Prognosis | 2 | 2018 | 3674 | 0.100 |
Why?
|
| Internet | 1 | 2013 | 312 | 0.100 |
Why?
|
| Conserved Sequence | 2 | 2003 | 210 | 0.090 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2010 | 1 | 0.090 |
Why?
|
| Leukemia Virus, Murine | 1 | 2010 | 18 | 0.090 |
Why?
|
| 5' Untranslated Regions | 1 | 2010 | 49 | 0.090 |
Why?
|
| Gestational Age | 1 | 2011 | 311 | 0.090 |
Why?
|
| Acetylation | 1 | 2010 | 121 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2020 | 3241 | 0.090 |
Why?
|
| Computational Biology | 1 | 2013 | 528 | 0.090 |
Why?
|
| Peritoneal Neoplasms | 2 | 2001 | 176 | 0.090 |
Why?
|
| Centromere | 1 | 2009 | 26 | 0.090 |
Why?
|
| Sarcoma | 2 | 2001 | 211 | 0.090 |
Why?
|
| Lysine | 1 | 2010 | 147 | 0.090 |
Why?
|
| Methylation | 1 | 2010 | 251 | 0.080 |
Why?
|
| Eukaryotic Cells | 1 | 2008 | 43 | 0.080 |
Why?
|
| Proviruses | 1 | 2008 | 15 | 0.080 |
Why?
|
| Wills | 1 | 2008 | 5 | 0.080 |
Why?
|
| Genes, Developmental | 1 | 2008 | 4 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1578 | 0.080 |
Why?
|
| Mosaicism | 1 | 2008 | 67 | 0.080 |
Why?
|
| Histones | 1 | 2010 | 311 | 0.080 |
Why?
|
| Lymph Nodes | 3 | 2000 | 530 | 0.070 |
Why?
|
| Body Patterning | 1 | 2009 | 209 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2004 | 46 | 0.070 |
Why?
|
| Plasmids | 1 | 2007 | 287 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2013 | 1351 | 0.070 |
Why?
|
| Skin Physiological Phenomena | 1 | 2006 | 27 | 0.070 |
Why?
|
| Rats | 1 | 2012 | 3990 | 0.070 |
Why?
|
| Crosses, Genetic | 1 | 2006 | 171 | 0.070 |
Why?
|
| Melanoma | 2 | 2000 | 454 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 2270 | 0.070 |
Why?
|
| Species Specificity | 1 | 2007 | 678 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2010 | 628 | 0.070 |
Why?
|
| Skin Neoplasms | 2 | 2000 | 541 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2004 | 379 | 0.060 |
Why?
|
| X Chromosome | 1 | 2005 | 152 | 0.060 |
Why?
|
| Fetal Proteins | 1 | 2004 | 17 | 0.060 |
Why?
|
| Dihematoporphyrin Ether | 2 | 2001 | 4 | 0.060 |
Why?
|
| Mesoderm | 1 | 2004 | 108 | 0.060 |
Why?
|
| Pregnancy | 1 | 2011 | 2893 | 0.060 |
Why?
|
| Takifugu | 1 | 2003 | 4 | 0.060 |
Why?
|
| Expressed Sequence Tags | 1 | 2003 | 35 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2004 | 270 | 0.060 |
Why?
|
| Genitalia | 1 | 2003 | 21 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2003 | 173 | 0.060 |
Why?
|
| RNA Splicing | 1 | 2004 | 142 | 0.060 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 2002 | 28 | 0.060 |
Why?
|
| Protein Binding | 2 | 2004 | 1456 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 229 | 0.060 |
Why?
|
| Tacrolimus | 1 | 2004 | 373 | 0.060 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 208 | 0.060 |
Why?
|
| Cell Line | 2 | 2015 | 2468 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2002 | 85 | 0.050 |
Why?
|
| Genotype | 1 | 2007 | 1850 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2002 | 85 | 0.050 |
Why?
|
| Genes, Synthetic | 1 | 2001 | 7 | 0.050 |
Why?
|
| Arm | 1 | 2002 | 91 | 0.050 |
Why?
|
| Leg | 1 | 2002 | 137 | 0.050 |
Why?
|
| Bone Development | 1 | 2001 | 34 | 0.050 |
Why?
|
| Hematoporphyrin Photoradiation | 1 | 2001 | 1 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2001 | 102 | 0.050 |
Why?
|
| Brain | 1 | 2011 | 2216 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 2001 | 76 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2001 | 244 | 0.050 |
Why?
|
| Survival Rate | 3 | 2001 | 1860 | 0.050 |
Why?
|
| Connective Tissue | 1 | 2020 | 23 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2000 | 11 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2000 | 15 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2001 | 252 | 0.050 |
Why?
|
| Zebrafish Proteins | 1 | 2002 | 144 | 0.050 |
Why?
|
| Tendons | 1 | 2020 | 44 | 0.050 |
Why?
|
| Neoplasm Transplantation | 1 | 2001 | 391 | 0.050 |
Why?
|
| Models, Biological | 1 | 2008 | 1749 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2001 | 127 | 0.050 |
Why?
|
| Cytokines | 1 | 2004 | 776 | 0.050 |
Why?
|
| Photochemotherapy | 1 | 2001 | 97 | 0.050 |
Why?
|
| Eye | 1 | 2020 | 111 | 0.050 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 1999 | 4 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2001 | 458 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2001 | 267 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 1041 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2001 | 790 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 557 | 0.040 |
Why?
|
| Muscle Development | 1 | 1999 | 41 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 439 | 0.040 |
Why?
|
| DNA | 2 | 2016 | 1294 | 0.040 |
Why?
|
| Keratins | 1 | 1999 | 63 | 0.040 |
Why?
|
| Response Elements | 1 | 1999 | 63 | 0.040 |
Why?
|
| Fetal Heart | 1 | 1998 | 13 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 1998 | 71 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2001 | 353 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 1047 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1998 | 126 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2001 | 2357 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1998 | 279 | 0.040 |
Why?
|
| Macrophages | 1 | 2001 | 554 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1998 | 291 | 0.040 |
Why?
|
| Spleen | 1 | 1998 | 430 | 0.040 |
Why?
|
| Carcinoma | 1 | 2001 | 436 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1998 | 468 | 0.040 |
Why?
|
| Foot Deformities, Congenital | 1 | 2016 | 10 | 0.040 |
Why?
|
| Hand Deformities, Congenital | 1 | 2016 | 15 | 0.040 |
Why?
|
| Facies | 1 | 2016 | 27 | 0.040 |
Why?
|
| SOX9 Transcription Factor | 1 | 2016 | 23 | 0.040 |
Why?
|
| Fluorouracil | 1 | 1998 | 556 | 0.040 |
Why?
|
| Transfection | 1 | 1998 | 896 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 579 | 0.040 |
Why?
|
| Up-Regulation | 1 | 1999 | 712 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2003 | 1196 | 0.040 |
Why?
|
| Fingers | 1 | 2016 | 68 | 0.030 |
Why?
|
| Myocardium | 1 | 1998 | 529 | 0.030 |
Why?
|
| Myeloid Ecotropic Viral Integration Site 1 Protein | 1 | 2015 | 20 | 0.030 |
Why?
|
| Radionuclide Imaging | 3 | 2000 | 220 | 0.030 |
Why?
|
| Apoptosis | 1 | 2001 | 1683 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 1999 | 2818 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 181 | 0.030 |
Why?
|
| Time Factors | 1 | 2001 | 5209 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1998 | 1313 | 0.030 |
Why?
|
| Gene Expression | 1 | 2016 | 1284 | 0.030 |
Why?
|
| Biopsy | 3 | 2000 | 1161 | 0.030 |
Why?
|
| Zebrafish | 1 | 2013 | 309 | 0.020 |
Why?
|
| Lymph Node Excision | 2 | 2000 | 213 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2001 | 1685 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 1999 | 2887 | 0.020 |
Why?
|
| Middle Aged | 5 | 2001 | 25017 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2001 | 3636 | 0.010 |
Why?
|
| Pennsylvania | 1 | 2001 | 75 | 0.010 |
Why?
|
| Laparotomy | 1 | 2001 | 59 | 0.010 |
Why?
|
| Adult | 4 | 2001 | 25640 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 2000 | 64 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2000 | 55 | 0.010 |
Why?
|
| Cytosol | 1 | 2000 | 189 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2000 | 122 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2000 | 316 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 429 | 0.010 |
Why?
|
| Rosaniline Dyes | 1 | 1999 | 9 | 0.010 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 1999 | 11 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2000 | 253 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2000 | 498 | 0.010 |
Why?
|
| Protein Transport | 1 | 2000 | 411 | 0.010 |
Why?
|
| Aged | 3 | 2001 | 18402 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 1999 | 179 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2001 | 1204 | 0.010 |
Why?
|
| Logistic Models | 1 | 2000 | 1185 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2000 | 1937 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1999 | 1753 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 1990 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2001 | 7988 | 0.000 |
Why?
|
| Adolescent | 1 | 2000 | 8979 | 0.000 |
Why?
|